Ibnova Therapeutics
PrivateLast Round
Accelerator
Mar 10, 2026
Total Funding Raised
$580,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ibnova Therapeutics is a biotechnology company developing next-generation vascularized engineered heart tissue patches to treat heart disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ibnova Therapeutics Comparables
Compare Ibnova Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avery Therapeutics, Inc. | 87% | |
| StemCardia | 77% | |
| Heartseed | 73% |
Ibnova Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Mar 10, 2026 |
Ibnova Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioInnovation Institute | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2026
$580K round led by BioInnovation Institute
Ibnova Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ibnova Therapeutics's valuation, stock price, and market status.
Is Ibnova Therapeutics a public or private company?
Ibnova Therapeutics is a private company.
What is the current stock price of Ibnova Therapeutics?
Ibnova Therapeutics is a private company with no public stock price. Caplight tracks Ibnova Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Ibnova Therapeutics worth (valuation)?
Valuation information for Ibnova Therapeutics is not publicly available.
Can I buy Ibnova Therapeutics stock?
Ibnova Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ibnova Therapeutics's last funding round?
Ibnova Therapeutics's most recent funding round was Accelerator on March 10, 2026.
Who are the main investors in Ibnova Therapeutics?
Key investors in Ibnova Therapeutics include BioInnovation Institute.
Will Ibnova Therapeutics IPO soon?
No public IPO plans have been announced for Ibnova Therapeutics.
How can I track Ibnova Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ibnova Therapeutics's secondary market activity and sign up for updates.